Ozonized Gel vs Gaseous Ozone Against S. Mutans in Deciduos Molars Caries
1 other identifier
interventional
16
1 country
1
Brief Summary
The aim of this study is to verify, through bacteriological analysis, the efficacy of reducing the bacterial load referred to the presence of Streptococcus Mutans in carious lesions of viable deciduous molars by application of gaseous ozone or ozonized gel. Patients who meet the eligibility criteria and for whom the legal guardians have signed the informed consent, will undergo treatment of the carious lesion with gaseous ozone or ozonized gel. After selective removal of dentin, a bacterial sample will be taken from the carious surface with a sterile paper cone at time T0; then ozone will be applied for 30 seconds, the surface will be washed with sterile saline and dried with air, a second sample will be taken at time T2; finally, ozone will be applied for another 30 seconds, the surface will be washed with sterile saline and dried with air, a third sample will be taken at time T2. Patients are then randomised into two groups: Test group: gaseous ozone (Healozone X4) is applied to the carious lesion for 30 seconds and then for another 30 seconds. Control group: ozone gel (GeliO3) will be applied to the carious lesion for 30 seconds and then for another 30 seconds. Changes in the following indices will be assessed at the first visit and when the samples are taken at T0, T1, T2: compliance assessment (FLACC scale), sensitivity test (Schiff Air Index), assessment of lesion severity and extent (ICDAS), assessment of gingival inflammation (GI), assessment of plaque index (PI), assessment of severity of enamel erosion (Bewe index).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 11, 2024
CompletedFirst Posted
Study publicly available on registry
October 15, 2024
CompletedStudy Start
First participant enrolled
October 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 5, 2025
CompletedApril 16, 2025
April 1, 2025
5 months
October 11, 2024
April 15, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in S. mutans counts
Evaluation of Colony forming units (CFU) of bacterials samples after treatment.
Baseline (T0), after 30 seconds (T1) and after 60 seconds (T2)
Secondary Outcomes (6)
Change in FLACC
Baseline (T0), and after 60 seconds (T2)
Change in Schiff Air Index
Baseline (T0), and after 60 seconds (T2)
Gingival Index (calculated on Ramfjiord teeth)
Baseline (T0)
Plaque Index (calculated on Ramfjiord teeth)
Baseline (T0)
ICDAS
Baseline (T0)
- +1 more secondary outcomes
Study Arms (2)
Ozone gel group
EXPERIMENTALGaseous ozone group
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Patients suffering from carious lesion on viable deciduous molar
- patients' compliance
You may not qualify if:
- patients with early loss of deciduous molars for carious lesions or orthodontic reasons
- non-viable deciduous molars
- deciduous molars with traumatic lesions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia
Pavia, Lombardy, 27100, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea Scribante, DDS, PhD
University of Pavia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Principal Investigator
Study Record Dates
First Submitted
October 11, 2024
First Posted
October 15, 2024
Study Start
October 21, 2024
Primary Completion
April 1, 2025
Study Completion
April 5, 2025
Last Updated
April 16, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share
Data will be available upon motivated request to the corresponding authors.